Plunkett Research Online: Corbus Pharmaceuticals Holdings Inc

CORBUS PHARMACEUTICALS HOLDINGS INC (CRBP:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Corbus Pharmaceuticals Holdings Inc functions in the healthcare sector of the United States. It is in the business of developing and commercializing drugs to cure chronic inflammatory diseases, cystic fibrosis, systemic sclerosis and skin-predominant dermatomyositis. Its main product candidate is Re.....



Corbus Pharmaceuticals Holdings Inc
Ticker: CRBP
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 617 963-0100
Fax:
Address: 500 River Ridge Drive
Second Floor
Norwood, MA 02062 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Vaccines, Skin Replacement Products and Biologicals Manufacturing
ContactsDescription
Yuval CohenCEO/Director
Sean MoranCFO/Chief Accounting Officer
See More
Corbus Pharmaceuticals Holdings Inc functions in the healthcare sector of the United States. It is in the business of developing and commercializing drugs to cure chronic inflammatory diseases, cystic fibrosis, systemic sclerosis and skin-predominant dermatomyositis. Its main product candidate is Re.....See More See More

Auditor: EisnerAmper LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
20172016201520142013
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: